Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy

Journal of Cardiovascular Medicine

Volumn 8, Issue 10, 2007, Pages 821-829

  Calore, Chiara ^a   Cacciavillani, Luisa ^a   Boffa, Giovanni Maria ^a   Silva, Caterina ^a   Tiso, Enrico ^a   Marra, Martina Perazzolo ^a   Bacchiega, Enrico ^a   Corbetti, Francesco ^b   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Cardiovascular magnetic resonance; Ischemic cardiomyopathy; Primary cardiomyopathy

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; INFORMATION; ISCHEMIC DILATED CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PATHOGENICITY; PRIMARY DILATED CARDIOMYOPATHY; SCAR FORMATION; SYSTOLE;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34748837265     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3280101e3c     Document Type: Article

References (30)

1. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59:634-638.
2. Adams KF, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28:1781-1788.
3. Bart BA, Shaw LK, McCants CB, Fortin DF, Lee KL, Califf RM, O'Connor CM. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or non-ischemic cardiomyopathy. J Am Coll Cardiol 1997; 30:1002-1008.
4. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2001; 104:2996-3007.
5. Beleslin BD, Ostojic M, Stepanovic J, Djorjevic-Dikic A, Stojkovic S, Nedeljkovic M, et al. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994; 90:1168-1176.
6. Vigna C, Russo C, De Rito V, Perna GP, Testa M, Lombardo A, et al. Regional wall motion analysis by dobutamine stress echography to distinguish between ischemic and non-ischemic dilated cardiomyopathy. Am Heart J 1996; 131:537-543.
7. Chikamori T, Doi YL, Yonezawa Y, Yamada M, Seo H, Ozawa T. Value of dipyridamole thallium-201 imaging in non-invasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 1993; 71:674-680.
8. Budoff MJ, Shavelle DM, Lamont DH, Kim HT, Akinwale P, Kennedy JM, et al. Usefulness of electron beam tomography scanning for distinguishing ischemic from non-ischemic cardiomyopathy. J Am Coll Cardiol 1998; 32:1173-1178.
9. Boffa GM, Zanco P, Della Valentina P, Cardaioli P, Thiene G, Chioin R, et al. Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy. Internat J Cardiol 2000; 74:67-74.
10. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318-3326.
11. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002.
12. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast enhancement magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
13. Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002; 23:602-619.
14. Rajappan K, Bellenger NG, Anderson L, Pennell DJ. The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2000; 2:241-252.
15. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 2003; 108:1945-1953.
16. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40:2156-2164.
17. McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108:54-59.
18. Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005; 45:743-748.
19. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223.
20. Blackburn H, Keys A, Simonson E, Rautahar P Jr. The electrocardiogram in population studies. A classification system. Circulation 1960; 21:1160-1175.
21. Grimm RH Jr, Tillinghast S, Daniels K, Neaton JD, Mascioli S, Crow R, et al. Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1987; 75:116-118.
22. Sheifer SE, Gersh BJ, Yanez ND III, Ades PA, Burker GL, Manolio TA. Prevalence, predisposing factors and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000; 35:119-126.
23. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for topographic imaging of the heart. Circulation 2002; 105:539-542.
24. Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Perazzolo Marra M, Bacchiega E, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty. A study performed with contrast enhanced magnetic resonance. J Am Coll Cardiol 2005; 46:1229-1235.
25. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357:21-28.
26. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-221.
27. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991; 83:26-37.
28. Galasko GI, Lahiri A. The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy - a myriad of techniques. Eur J Heart Fail 2003; 5:217-227.
29. Gunning MG, Kaprielian RR, Pepper J, Pennell DJ, Sheppard MN, Severs NJ, et al. The histology of viable and hibernating myocardium in relation to imaging characteristics. J Am Coll Cardiol 2002; 39:428-435.
30. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002; 39:210-218.